Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

PDSB — PDS Biotechnology Corp SEC Filings | FilingIndex

PDSBNasdaq

PDS Biotechnology Corp

Pharmaceutical Preparations · DE · CIK 1472091

Developing targeted cancer and infectious disease immunotherapies using proprietary T cell activators

+ Watch View on EDGAR ↗

$59M

Market cap

$0.88

Last close

-2.0%

1D

-3.4%

5D

193K

Volume

Price · last 40 sessions-11.9%

May 4L $0.87 · H $1.43Jun 30

376

Total filings

Jun 26, 2026

Last filing

12/31

Fiscal year end

All 8-K · 266 10-Q · 32 DEFA14A · 12 DEF 14A · 12 10-K · 11 424B5 · 8 SC 13G · 7 425 · 7

DEF 14ADEF 14AJun 26, 2026 DEF 14ADEF 14AApr 29, 2025 DEF 14ADEF 14AApr 29, 2024 DEF 14ADEF 14AJun 2, 2023 DEF 14ADEF 14AApr 29, 2022 DEF 14A

Similar companies

Comparable business profile · signals at a glance

ELTXElicio Therapeutics, Inc.$283.4M-2.3%CADLCandel Therapeutics, Inc.$627.2M-0.6%REPLReplimune Group, Inc.$733.2M-1.2%PGENPRECIGEN, INC.$1.6B-3.7%IOVAIOVANCE BIOTHERAPEUTICS, INC.

DEF 14A

Dec 16, 2021

DEF 14ADEF 14AApr 29, 2021

DEF 14ADEF 14AApr 29, 2020

DEF 14ADEF 14AAug 16, 2019

DEF 14ADEF 14AApr 25, 2018

DEF 14ADEF 14AApr 28, 2017

DEF 14ADEF 14AApr 28, 2016

$1.8B

-1.2%

ANIXAnixa Biosciences Inc$84.0M-1.8%